Dr. Lara Davis is an Associate Professor at Oregon Health & Science University (OHSU), where she is the Sarcoma Program Director and co-leads the Translational Oncology Program of the Knight Cancer Institute. She completed combined training in Medical Oncology and Pediatric Hematology/Oncology in order to pursue a career in adolescent and young adult sarcoma care. Dr. Davis runs a number of clinical trials, including SARC038, a phase 2 trial of nivolumab and regorafenib for osteosarcoma, which she co-leads with Dr. Fariba Navid of CHLA. In addition, Dr. Davis directs translational osteosarcoma research at the Knight Cancer Institute’s Center for Experimental Therapeutics. She is the recipient of an NCI Cancer Clinical Investigator Team Leadership Award as well as career development awards from SARC and the St. Baldrick’s Foundation.